H. Rept. 116-44 Part 1- Protecting Americans with Preexisting Conditions Act of 2019, 2019-04-30
Date | 30 April 2019 |
Type of Document | House Report |
Issuer | Committee on Energy and Commerce |
89–006
116
TH
C
ONGRESS
R
EPT
. 116–44
" !
HOUSE OF REPRESENTATIVES
1st Session Part 1
PROTECTING AMERICANS WITH PREEXISTING
CONDITIONS ACT OF 2019
A
PRIL
30, 2019.—Committed to the Committee on the Whole House on the State of
the Union and ordered to be printed
Mr. P
ALLONE
, from the Committee on Energy and Commerce,
submitted the following
R E P O R T
together with
DISSENTING VIEWS
[To accompany H.R. 986]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 986) to provide that certain guidance related to waiv-
ers for State innovation under the Patient Protection and Afford-
able Care Act shall have no force or effect, having considered the
same, report favorably thereon without amendment and rec-
ommend that the bill do pass.
CONTENTS Page
I. Purpose and Summary ............................................................................... 2
II. Background and Need for the Legislation ................................................ 2
III. Committee Hearings ................................................................................... 3
IV. Committee Consideration ........................................................................... 3
V. Committee Votes ......................................................................................... 3
VI. Oversight Findings ...................................................................................... 3
VII. New Budget Authority, Entitlement Authority, and Tax Expenditures
VIII. Congressional Budget Office Estimate ...................................................... 3
IX. Federal Mandates Statement ..................................................................... 5
X. Statement of General Performance Goals and Objectives ....................... 5
XI. Duplication of Federal Programs ............................................................... 5
XII. Committee Cost Estimate ........................................................................... 5
XIII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits ............... 5
XIV. Advisory Committee Statement ................................................................. 5
XV. Applicability to Legislative Branch ........................................................... 5
XVI. Section-by-Section Analysis of the Legislation ......................................... 5
XVII. Changes in Existing Law Made by the Bill, as Reported ........................ 6
XVIII. Dissenting Views ......................................................................................... 7
VerDate Sep 11 2014 04:20 May 01, 2019 Jkt 089006 PO 00000 Frm 00001 Fmt 6659 Sfmt 6646 E:\HR\OC\HR044P1.XXX HR044P1
lotter on DSKBCFDHB2PROD with REPORTS
To continue reading
Request your trial